These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17532415)

  • 1. Selective endothelin-A receptor inhibition after cardiac surgery: a safety and feasibility study.
    Ikonomidis JS; Hilton EJ; Payne K; Harrell A; Finklea L; Clark L; Reeves S; Stroud RE; Leonardi A; Crawford FA; Spinale FG
    Ann Thorac Surg; 2007 Jun; 83(6):2153-60; discussion 2161. PubMed ID: 17532415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective endothelin-1 receptor type A inhibition in subjects undergoing cardiac surgery with preexisting left ventricular dysfunction: Influence on early postoperative hemodynamics.
    Toole JM; Ikonomidis JS; Szeto WY; Zellner JL; Mulcahy J; Deardorff RL; Spinale FG
    J Thorac Cardiovasc Surg; 2010 Mar; 139(3):646-54. PubMed ID: 20074751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin receptor subtype A blockade selectively reduces pulmonary pressure after cardiopulmonary bypass.
    Joffs C; Walker CA; Hendrick JW; Fary DJ; Almany DK; Davis JN; Goldberg AT; Crawford FA; Spinale FG
    J Thorac Cardiovasc Surg; 2001 Aug; 122(2):365-70. PubMed ID: 11479511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin-A receptor inhibition after cardiopulmonary bypass: cytokines and receptor activation.
    Ford RL; Mains IM; Hilton EJ; Reeves ST; Stroud RE; Crawford FA; Ikonomidis JS; Spinale FG
    Ann Thorac Surg; 2008 Nov; 86(5):1576-83. PubMed ID: 19049753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease.
    Girgis RE; Frost AE; Hill NS; Horn EM; Langleben D; McLaughlin VV; Oudiz RJ; Robbins IM; Seibold JR; Shapiro S; Tapson VF; Barst RJ
    Ann Rheum Dis; 2007 Nov; 66(11):1467-72. PubMed ID: 17472992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin mediates increased pulmonary vascular tone in patients with heart failure: demonstration by direct intrapulmonary infusion of sitaxsentan.
    Ooi H; Colucci WS; Givertz MM
    Circulation; 2002 Sep; 106(13):1618-21. PubMed ID: 12270852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiopulmonary bypass decreases pulmonary vascular resistance index after coronary artery bypass surgery.
    Toikkanen V; Rinne T; Huhtala H; Laurikka J; Porkkala H; Tarkka M; Mennander A
    Scand J Clin Lab Invest; 2014 Jan; 74(1):37-43. PubMed ID: 24266780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of hyperoncotic cardiopulmonary bypass prime on extravascular lung water and cardiopulmonary function in patients undergoing coronary artery bypass surgery].
    Jin X; Chen Z; Wang M; Lü W; Zhang W; Sun J
    Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(9):646-50. PubMed ID: 24842200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial.
    Tripathi D; Therapondos G; Ferguson JW; Newby DE; Webb DJ; Hayes PC
    Gut; 2006 Sep; 55(9):1290-5. PubMed ID: 16434427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does a hyperoncotic cardiopulmonary bypass prime affect extravascular lung water and cardiopulmonary function in patients undergoing coronary artery bypass surgery?
    Eising GP; Niemeyer M; Günther T; Tassani P; Pfauder M; Schad H; Lange R
    Eur J Cardiothorac Surg; 2001 Aug; 20(2):282-9. PubMed ID: 11463545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal synthesis and release of endothelin within the systemic and myocardial circulation during and after cardiopulmonary bypass: relation to postoperative recovery.
    Dorman BH; Bond BR; Clair MJ; Walker CA; Pinosky ML; Reeves ST; Kratz JM; Zellner JL; Crumbley AJ; Multani MM; Spinale FG
    J Cardiothorac Vasc Anesth; 2000 Oct; 14(5):540-5. PubMed ID: 11052435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, randomized study of endothelin and postoperative recovery in off-pump versus conventional coronary artery bypass surgery.
    Dorman BH; Kratz JM; Multani MM; Baron R; Farrar E; Walton S; Payne K; Ikonomiois J; Reeves S; Mukherjee R; Spinale FG
    J Cardiothorac Vasc Anesth; 2004 Feb; 18(1):25-9. PubMed ID: 14973794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Greater functional ETB receptor antagonism with bosentan than sitaxsentan in healthy men.
    MacIntyre IM; Dhaun N; Lilitkarntakul P; Melville V; Goddard J; Webb DJ
    Hypertension; 2010 Jun; 55(6):1406-11. PubMed ID: 20404221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-cardiopulmonary bypass pulmonary hypertension in lambs with increased pulmonary blood flow. A role for endothelin 1.
    Reddy VM; Hendricks-Munoz KD; Rajasinghe HA; Petrossian E; Hanley FL; Fineman JR
    Circulation; 1997 Feb; 95(4):1054-61. PubMed ID: 9054770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-A receptor blockade in porcine pulmonary hypertension.
    Ambalavanan N; Philips JB; Bulger A; Oparil S; Chen YF
    Pediatr Res; 2002 Dec; 52(6):913-21. PubMed ID: 12438670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of post-cardiopulmonary bypass acute kidney injury by endothelin A receptor blockade.
    Patel NN; Toth T; Jones C; Lin H; Ray P; George SJ; Welsh G; Satchell SC; Sleeman P; Angelini GD; Murphy GJ
    Crit Care Med; 2011 Apr; 39(4):793-802. PubMed ID: 21220998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative hemodynamics depend on cardiopulmonary bypass temperature: the potential role of endothelin-1.
    Tönz M; Mihaljevic T; von Segesser LK; Shaw S; Lüscher TF; Turina M
    Eur J Cardiothorac Surg; 1997 Jan; 11(1):157-61. PubMed ID: 9030805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: open-label pilot study.
    Barst RJ; Rich S; Widlitz A; Horn EM; McLaughlin V; McFarlin J
    Chest; 2002 Jun; 121(6):1860-8. PubMed ID: 12065350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of STRIDE-2 and STRIDE-2X: the case for selective endothelin receptor blockade.
    Langleben D; Cacoub P
    Eur J Clin Invest; 2009 Jun; 39 Suppl 2():27-31. PubMed ID: 19335744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.